{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T18:52:22Z","timestamp":1790275942330,"version":"4.1.0"},"reference-count":106,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2016,1,1]],"date-time":"2016-01-01T00:00:00Z","timestamp":1451606400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cytokine"],"published-print":{"date-parts":[[2016,1]]},"DOI":"10.1016\/j.cyto.2015.09.017","type":"journal-article","created":{"date-parts":[[2015,10,5]],"date-time":"2015-10-05T10:16:13Z","timestamp":1444040173000},"page":"189-195","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":51,"special_numbering":"C","title":["Interleukin 4 inhibition as a potential therapeutic in pemphigus"],"prefix":"10.1016","volume":"77","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6765-8830","authenticated-orcid":false,"given":"Soheil","family":"Tavakolpour","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vahid","family":"Tavakolpour","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.cyto.2015.09.017_b0005","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1155\/2012\/925135","article-title":"CD4+T cells: differentiation and functions","volume":"2012","author":"Luckheeram","year":"2012","journal-title":"Clin. Dev. Immunol."},{"key":"10.1016\/j.cyto.2015.09.017_b0010","series-title":"T Helper Cell Differentiation and Their Function","author":"Sun","year":"2014"},{"key":"10.1016\/j.cyto.2015.09.017_b0015","doi-asserted-by":"crossref","first-page":"1288","DOI":"10.1038\/ni.1656","article-title":"Priming for T helper type 2 differentiation by interleukin 2-mediated induction of interleukin 4 receptor \u03b1-chain expression","volume":"9","author":"Liao","year":"2008","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.cyto.2015.09.017_b0020","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1111\/j.1365-2567.2008.02845.x","article-title":"Control of IL-4 expression in T helper 1 and 2 cells","volume":"124","author":"Gilmour","year":"2008","journal-title":"Immunology"},{"key":"10.1016\/j.cyto.2015.09.017_b0025","doi-asserted-by":"crossref","first-page":"3627","DOI":"10.4049\/jimmunol.171.7.3627","article-title":"Identification of novel IL-4\/Stat6-regulated genes in T lymphocytes","volume":"171","author":"Chen","year":"2003","journal-title":"J. Immunol."},{"key":"10.1016\/j.cyto.2015.09.017_b0030","doi-asserted-by":"crossref","unstructured":"J.D. Farrar, H. Asnagli, K.M. Murphy, T helper subset development: roles of instruction, selection, and transcription, 2002.","DOI":"10.1172\/JCI200215093"},{"key":"10.1016\/j.cyto.2015.09.017_b0035","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1038\/nm1551","article-title":"A brief history of TH17, the first major revision in the TH1\/TH2 hypothesis of T cell\u2013mediated tissue damage","volume":"13","author":"Steinman","year":"2007","journal-title":"Nat. Med."},{"key":"10.1016\/j.cyto.2015.09.017_b0040","series-title":"Animal Models of T Cell-Mediated Skin Diseases","first-page":"235","article-title":"Pro-and anti-inflammatory effects of IL-4: from studies in mice to therapy of autoimmune diseases in humans","author":"Biedermann","year":"2005"},{"key":"10.1016\/j.cyto.2015.09.017_b0045","doi-asserted-by":"crossref","first-page":"3796","DOI":"10.4049\/jimmunol.145.11.3796","article-title":"IL-4 directs the development of Th2-like helper effectors","volume":"145","author":"Swain","year":"1990","journal-title":"J. Immunol."},{"key":"10.1016\/j.cyto.2015.09.017_b0050","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1084\/jem.172.3.921","article-title":"Generation of interleukin 4 (IL-4)-producing cells in vivo and in vitro: IL-2 and IL-4 are required for in vitro generation of IL-4-producing cells","volume":"172","author":"Le Gros","year":"1990","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.cyto.2015.09.017_b0055","doi-asserted-by":"crossref","first-page":"6065","DOI":"10.1073\/pnas.89.13.6065","article-title":"Differential regulation of T helper phenotype development by interleukins 4 and 10 in an alpha beta T-cell-receptor transgenic system","volume":"89","author":"Hsieh","year":"1992","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.cyto.2015.09.017_b0060","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1084\/jem.176.4.1091","article-title":"The presence of interleukin 4 during in vitro priming determines the lymphokine-producing potential of CD4+ T cells from T cell receptor transgenic mice","volume":"176","author":"Seder","year":"1992","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.cyto.2015.09.017_b0065","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.1016\/0091-6749(94)90332-8","article-title":"Acquisition of lymphokine-producing phenotype by CD4+ T cells","volume":"94","author":"Seder","year":"1994","journal-title":"J. Allergy Clin. Immunol."},{"key":"10.1016\/j.cyto.2015.09.017_b0070","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/j.immuni.2011.12.014","article-title":"Interleukin-4 production by follicular helper T cells requires the conserved Il4 enhancer hypersensitivity site V","volume":"36","author":"Vijayanand","year":"2012","journal-title":"Immunity"},{"key":"10.1016\/j.cyto.2015.09.017_b0075","first-page":"223","article-title":"Th1\/Th2 balance: the hypothesis, its limitations, and implications for health and disease","volume":"8","author":"Kidd","year":"2003","journal-title":"Altern. Med. Rev."},{"key":"10.1016\/j.cyto.2015.09.017_b0080","doi-asserted-by":"crossref","first-page":"427","DOI":"10.3109\/08916934.2012.697593","article-title":"Cytokine networks in Pemphigus vulgaris: an integrated viewpoint","volume":"45","author":"Giordano","year":"2012","journal-title":"Autoimmunity"},{"key":"10.1016\/j.cyto.2015.09.017_b0085","series-title":"Autoimmune Diseases of the Skin: Pathogenesis, Diagnosis, Management","author":"Hertl","year":"2011"},{"key":"10.1016\/j.cyto.2015.09.017_b0090","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1111\/j.1365-4632.2004.02533.x","article-title":"Pemphigus in the Mediterranean region of Turkey: a study of 148 cases","volume":"45","author":"Uzun","year":"2006","journal-title":"Int. J. Dermatol."},{"key":"10.1016\/j.cyto.2015.09.017_b0095","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1111\/j.1365-4632.2004.02501.x","article-title":"Pemphigus: analysis of 1209 cases","volume":"44","author":"Chams-Davatchi","year":"2005","journal-title":"Int. J. Dermatol."},{"key":"10.1016\/j.cyto.2015.09.017_b0100","first-page":"157","article-title":"Epidemiology of pemphigus in Hamedan (west of Iran): a 10 year retrospective study (1995\u20132004)","volume":"1","author":"Yazdanfar","year":"2010","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.cyto.2015.09.017_b0105","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1046\/j.1365-4362.1998.00428.x","article-title":"Epidemiologic analysis and clinical course of 84 consecutive cases of pemphigus in eastern Sicily","volume":"37","author":"Micali","year":"1998","journal-title":"Int. J. Dermatol."},{"key":"10.1016\/j.cyto.2015.09.017_b0110","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1001\/archderm.1974.01630120012002","article-title":"Pemphigus: epidemiologic and survival characteristics of 59 patients, 1955\u20131973","volume":"110","author":"Krain","year":"1974","journal-title":"Arch. Dermatol."},{"key":"10.1016\/j.cyto.2015.09.017_b0115","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1046\/j.1365-4362.2001.01124.x","article-title":"Pemphigus in South Africa","volume":"40","author":"Aboobaker","year":"2001","journal-title":"Int. J. Dermatol."},{"key":"10.1016\/j.cyto.2015.09.017_b0120","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/S0190-9622(99)70183-0","article-title":"The clinical phenotype of pemphigus is defined by the anti-desmoglein autoantibody profile","volume":"40","author":"Amagai","year":"1999","journal-title":"J. Am. Acad. Dermatol."},{"key":"10.1016\/j.cyto.2015.09.017_b0125","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1016\/0092-8674(91)90360-B","article-title":"Autoantibodies against a novel epithelial cadherin in pemphigus vulgaris, a disease of cell adhesion","volume":"67","author":"Amagai","year":"1991","journal-title":"Cell"},{"key":"10.1016\/j.cyto.2015.09.017_b0130","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1111\/j.1365-2133.2012.10827.x","article-title":"Five Japanese cases of antidesmoglein 1 antibody-positive and antidesmoglein 3 antibody-negative pemphigus with oral lesions","volume":"166","author":"Koga","year":"2012","journal-title":"Br. J. Dermatol."},{"key":"10.1016\/j.cyto.2015.09.017_b0135","first-page":"1901","article-title":"Nonsecretory IgA1 autoantibodies targeting desmosomal component desmoglein 3 in intraepidermal neutrophilic IgA dermatosis","volume":"150","author":"Wang","year":"1997","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.cyto.2015.09.017_b0140","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/0923-1811(95)00449-1","article-title":"Studies of autoantigens recognized by IgA anti-keratinocyte cell surface antibodies","volume":"12","author":"Hashimoto","year":"1996","journal-title":"J. Dermatol. Sci."},{"key":"10.1016\/j.cyto.2015.09.017_b0145","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/S0923-1811(00)00158-4","article-title":"Predominant IgG4 subclass in autoantibodies of pemphigus vulgaris and foliaceus","volume":"26","author":"Futei","year":"2001","journal-title":"J. Dermatol. Sci."},{"key":"10.1016\/j.cyto.2015.09.017_b0150","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.1111\/j.1365-2133.2012.11144.x","article-title":"Enrichment of total serum IgG4 in patients with pemphigus","volume":"167","author":"Funakoshi","year":"2012","journal-title":"Br. J. Dermatol."},{"key":"10.1016\/j.cyto.2015.09.017_b0155","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1046\/j.1523-1747.2003.12017.x","article-title":"The role of subclass switching in the pathogenesis of endemic pemphigus foliaceus","volume":"120","author":"Warren","year":"2003","journal-title":"J. Invest. Dermatol."},{"key":"10.1016\/j.cyto.2015.09.017_b0160","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1159\/000246938","article-title":"Correlation of subclasses of IgG with disease activity in pemphigus vulgaris","volume":"189","author":"Bhol","year":"1994","journal-title":"Dermatology"},{"key":"10.1016\/j.cyto.2015.09.017_b0165","doi-asserted-by":"crossref","first-page":"1621","DOI":"10.1001\/archdermatol.2008.503","article-title":"Effect of intravenous immunoglobulin therapy on serum levels of IgG1 and IgG4 antidesmoglein 1 and antidesmoglein 3 antibodies in pemphigus vulgaris","volume":"144","author":"Green","year":"2008","journal-title":"Arch. Dermatol."},{"key":"10.1016\/j.cyto.2015.09.017_b0170","doi-asserted-by":"crossref","first-page":"516","DOI":"10.3109\/08916934.2012.702811","article-title":"Specific immunoglobulin isotypes correlate with disease activity, morphology, duration and HLA association in Pemphigus vulgaris","volume":"45","author":"Dhandha","year":"2012","journal-title":"Autoimmunity"},{"key":"10.1016\/j.cyto.2015.09.017_b0175","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1007\/s10875-011-9597-4","article-title":"Cognate Th2\u2013B cell interaction is essential for the autoantibody production in pemphigus vulgaris","volume":"32","author":"Zhu","year":"2012","journal-title":"J. Clin. Immunol."},{"key":"10.1016\/j.cyto.2015.09.017_b0180","doi-asserted-by":"crossref","first-page":"3883","DOI":"10.4049\/jimmunol.172.6.3883","article-title":"T cell recognition of desmoglein 3 peptides in patients with pemphigus vulgaris and healthy individuals","volume":"172","author":"Veldman","year":"2004","journal-title":"J. Immunol."},{"key":"10.1016\/j.cyto.2015.09.017_b0185","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1111\/j.1365-2230.2005.01836.x","article-title":"Direct characterization of human T cells in pemphigus vulgaris reveals elevated autoantigen-specific Th2 activity in association with active disease","volume":"30","author":"Rizzo","year":"2005","journal-title":"Clin. Exp. Dermatol."},{"key":"10.1016\/j.cyto.2015.09.017_b0190","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1172\/JCI2250","article-title":"Role of interleukin 10 in specific immunotherapy","volume":"102","author":"Akdis","year":"1998","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.cyto.2015.09.017_b0195","doi-asserted-by":"crossref","first-page":"4718","DOI":"10.4049\/jimmunol.174.8.4718","article-title":"T regulatory-1 cells induce IgG4 production by B cells: role of IL-10","volume":"174","author":"Satoguina","year":"2005","journal-title":"J. Immunol."},{"key":"10.1016\/j.cyto.2015.09.017_b0200","doi-asserted-by":"crossref","first-page":"3555","DOI":"10.4049\/jimmunol.160.7.3555","article-title":"IgE versus IgG4 production can be differentially regulated by IL-10","volume":"160","author":"Jeannin","year":"1998","journal-title":"J. Immunol."},{"key":"10.1016\/j.cyto.2015.09.017_b0205","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1084\/jem.167.1.183","article-title":"Differential regulation of IgG1 and IgE synthesis by interleukin 4","volume":"167","author":"Snapper","year":"1988","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.cyto.2015.09.017_b0210","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1111\/j.1600-065X.1988.tb00741.x","article-title":"Regulation of IgG1 and IgE production by interleukin 4","volume":"102","author":"Snapper","year":"1988","journal-title":"Immunol. Rev."},{"key":"10.1016\/j.cyto.2015.09.017_b0215","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1084\/jem.168.3.853","article-title":"Interleukin 4 causes isotype switching to IgE in T cell-stimulated clonal B cell cultures","volume":"168","author":"Lebman","year":"1988","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.cyto.2015.09.017_b0220","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1084\/jem.173.3.747","article-title":"Human B cell clones can be induced to proliferate and to switch to IgE and IgG4 synthesis by interleukin 4 and a signal provided by activated CD4+ T cell clones","volume":"173","author":"Gascan","year":"1991","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.cyto.2015.09.017_b0225","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1111\/j.1365-2249.1990.tb08101.x","article-title":"The inductive effect of interleukin-4 on IgG4 and IgE synthesis in human peripheral blood lymphocytes","volume":"79","author":"Ishizaka","year":"1990","journal-title":"Clin. Exp. Immunol."},{"key":"10.1016\/j.cyto.2015.09.017_b0230","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1080\/08820130902943097","article-title":"Involvement of TH1\/TH2 cytokines in the pathogenesis of autoimmune skin disease\u2014pemphigus vulgaris","volume":"38","author":"Satyam","year":"2009","journal-title":"Immunol. Invest."},{"key":"10.1016\/j.cyto.2015.09.017_b0235","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1006\/clim.2000.4974","article-title":"Further support for a role for Th2-like cytokines in blister formation of pemphigus","volume":"98","author":"Caproni","year":"2001","journal-title":"Clin. Immunol."},{"key":"10.1016\/j.cyto.2015.09.017_b0240","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1172\/JCI119130","article-title":"Development and characterization of desmoglein-3 specific T cells from patients with pemphigus vulgaris","volume":"99","author":"Lin","year":"1997","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.cyto.2015.09.017_b0245","first-page":"83","article-title":"Cytokine profiles in the sera of Egyptian patients with oral pemphigus vulgaris","volume":"10","author":"Eid","year":"2011","journal-title":"Braz. J. Oral Sci."},{"key":"10.1016\/j.cyto.2015.09.017_b0250","unstructured":"H. Mortazavi, A. Amirzargar, M. Valikhani, Z. Halaji, P.M. Danesh, T.M. Nazemi, et al., The Influence of Treatment of Pemphigus Vulgarison the Serum Level of Cytokines, 2008."},{"key":"10.1016\/j.cyto.2015.09.017_b0255","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1590\/S0100-879X2000000900012","article-title":"Serum cytokines in patients with Brazilian pemphigus foliaceus (fogo selvagem)","volume":"33","author":"Zeoti","year":"2000","journal-title":"Braz. J. Med. Biol. Res."},{"key":"10.1016\/j.cyto.2015.09.017_b0260","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1046\/j.1365-2133.1999.02907.x","article-title":"Characterization of skin cytokines in bullous pemphigoid and pemphigus vulgaris","volume":"140","author":"Rico","year":"1999","journal-title":"Br. J. Dermatol."},{"key":"10.1016\/j.cyto.2015.09.017_b0265","doi-asserted-by":"crossref","DOI":"10.1016\/j.jaci.2010.11.050","article-title":"Interleukins, from 1 to 37, and interferon-\u03b3: receptors, functions, and roles in diseases","volume":"127","author":"Akdis","year":"2011","journal-title":"J. Allergy Clin. Immunol."},{"key":"10.1016\/j.cyto.2015.09.017_b0270","doi-asserted-by":"crossref","first-page":"1874","DOI":"10.1126\/science.8266076","article-title":"Sharing of the interleukin-2 (IL-2) receptor gamma chain between receptors for IL-2 and IL-4","volume":"262","author":"Kondo","year":"1993","journal-title":"Science"},{"key":"10.1016\/j.cyto.2015.09.017_b0275","doi-asserted-by":"crossref","first-page":"1880","DOI":"10.1126\/science.8266078","article-title":"Interleukin-2 receptor gamma chain: a functional component of the interleukin-4 receptor","volume":"262","author":"Russell","year":"1993","journal-title":"Science"},{"key":"10.1016\/j.cyto.2015.09.017_b0280","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/1074-7613(95)90141-8","article-title":"The role of shared receptor motifs and common Stat proteins in the generation of cytokine pleiotropy and redundancy by IL-2, IL-4, IL-7, IL-13, and IL-15","volume":"2","author":"Lin","year":"1995","journal-title":"Immunity"},{"key":"10.1016\/j.cyto.2015.09.017_b0285","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1002\/jlb.65.3.307","article-title":"Inhibition of IL-4-inducible gene expression in human monocytes by type I and type II interferons","volume":"65","author":"Dickensheets","year":"1999","journal-title":"J. Leukoc. Biol."},{"key":"10.1016\/j.cyto.2015.09.017_b0290","first-page":"215","article-title":"Interleukin-4: a multifunctional cytokine","volume":"22","author":"Zamorano","year":"2003","journal-title":"Immunologia"},{"key":"10.1016\/j.cyto.2015.09.017_b0295","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1385\/IR:28:1:25","article-title":"The function role of GATA-3 in Th1 and Th2 differentiation","volume":"28","author":"Zhou","year":"2003","journal-title":"Immunol. Res."},{"key":"10.1016\/j.cyto.2015.09.017_b0300","doi-asserted-by":"crossref","first-page":"1859","DOI":"10.1084\/jem.188.10.1859","article-title":"C-maf promotes T helper cell type 2 (Th2) and attenuates Th1 differentiation by both interleukin 4\u2013dependent and\u2013independent mechanisms","volume":"188","author":"Ho","year":"1998","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.cyto.2015.09.017_b0305","doi-asserted-by":"crossref","DOI":"10.1155\/2012\/416739","article-title":"Changes in the Th1: Th2 cytokine bias in pregnancy and the effects of the anti-inflammatory cyclopentenone prostaglandin 15-deoxy\u2013prostaglandin","volume":"2012","author":"Sykes","year":"2012","journal-title":"Mediators Inflamm."},{"key":"10.1016\/j.cyto.2015.09.017_b0310","doi-asserted-by":"crossref","DOI":"10.1155\/2012\/967629","article-title":"The Th1: th2 dichotomy of pregnancy and preterm labour","volume":"2012","author":"Sykes","year":"2012","journal-title":"Mediators Inflamm."},{"key":"10.1016\/j.cyto.2015.09.017_b0315","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1097\/OGX.0b013e3181bea089","article-title":"Pemphigus vulgaris in pregnancy: analysis of current data on the management and outcomes","volume":"64","author":"Kardos","year":"2009","journal-title":"Obstet. Gynecol. Surv."},{"key":"10.1016\/j.cyto.2015.09.017_b0320","doi-asserted-by":"crossref","first-page":"534","DOI":"10.4103\/0378-6323.82404","article-title":"Pemphigus and pregnancy: a 23-year experience","volume":"77","author":"Daneshpazhooh","year":"2011","journal-title":"Indian J. Dermatol., Venereol., Leprol."},{"key":"10.1016\/j.cyto.2015.09.017_b0325","unstructured":"Action IPAI-LAIPAI-L, <http:\/\/www.fda.gov\/Drugs\/DevelopmentApprovalProcess\/HowDrugsareDevelopedandApproved\/ApprovalApplications\/TherapeuticBiologicApplications\/ucm093327.htm>."},{"key":"10.1016\/j.cyto.2015.09.017_b0330","unstructured":"Information on Tumor Necrosis Factor (TNF) Blockers (marketed as Remicade E, Humira, Cimzia, and Simponi) (Information on Tumor Necrosis Factor (TNF) Blockers (marketed as Remicade, Enbrel, Humira, Cimzia, and Simponi)), <http:\/\/www.fda.gov\/Drugs\/DrugSafety\/PostmarketDrugSafetyInformationforPatientsandProviders\/ucm109340.htm>."},{"key":"10.1016\/j.cyto.2015.09.017_b0335","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/j.clim.2012.11.001","article-title":"Cytokine inhibition as a strategy for treating systemic lupus erythematosus","volume":"148","author":"Clark","year":"2013","journal-title":"Clin. Immunol."},{"key":"10.1016\/j.cyto.2015.09.017_b0340","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1111\/bjd.13350","article-title":"A multicentre randomized trial of the treatment of patients with pemphigus vulgaris with infliximab and prednisone compared with prednisone alone","volume":"172","author":"Hall","year":"2015","journal-title":"Br. J. Dermatol."},{"key":"10.1016\/j.cyto.2015.09.017_b0345","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1111\/bjd.13664","article-title":"To (anti-) TNF or not (anti-) TNF? That is the question in pemphigus","volume":"172","author":"Sinha","year":"2015","journal-title":"Br. J. Dermatol."},{"key":"10.1016\/j.cyto.2015.09.017_b0350","unstructured":"Jos\u00e9 Antonio Delgado Garc\u00eda, Carmen P\u00e9rez Robles, Juan Jos\u00e9 Mata Molanes, Laura Moreno Narro, Paula Arana Berganza, Level of IgG4 anti-desmoglein 3 antibodies correlates with disease activity in patients with pemphigus vulgaris, Autoimmun Infec. Dis. 1.1 (2005). http:\/\/dx.doi.org\/10.16966\/aidoa.101."},{"key":"10.1016\/j.cyto.2015.09.017_b0355","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1111\/j.0105-2896.2006.00420.x","article-title":"Interleukin-10-secreting type 1 regulatory T cells in rodents and humans","volume":"212","author":"Grazia Roncarolo","year":"2006","journal-title":"Immunol. Rev."},{"key":"10.1016\/j.cyto.2015.09.017_b0360","doi-asserted-by":"crossref","first-page":"1742","DOI":"10.1182\/blood.V97.6.1742","article-title":"Selective inhibition of interleukin-4 gene expression in human T cells by aspirin","volume":"97","author":"Cianferoni","year":"2001","journal-title":"Blood"},{"key":"10.1016\/j.cyto.2015.09.017_b0365","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/0162-3109(89)90045-3","article-title":"Aspirin and thymosin increase interleukin-2 and interferon-\u03b3 production by human peripheral blood lymphocytes","volume":"17","author":"Hsia","year":"1989","journal-title":"Immunopharmacology"},{"key":"10.1016\/j.cyto.2015.09.017_b0370","doi-asserted-by":"crossref","first-page":"1428","DOI":"10.4049\/jimmunol.168.3.1428","article-title":"Aspirin and salicylates inhibit the IL-4-and IL-13-induced activation of STAT6","volume":"168","author":"Perez-G","year":"2002","journal-title":"J. Immunol."},{"key":"10.1016\/j.cyto.2015.09.017_b0375","first-page":"400","article-title":"Interleukin-2 inhibits the interleukin-4-induced human IgE and IgG4 secretion in vivo","volume":"84","author":"Spiegelberg","year":"1991","journal-title":"Clin. Exp. Immunol."},{"key":"10.1016\/j.cyto.2015.09.017_b0380","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1007\/s00403-014-1522-2","article-title":"Study of T helper 1 and T helper 2 responses in pemphigus vulgaris patients receiving interferon alpha 2a injections in addition to a standard protocol therapy: a randomized controlled trial","volume":"307","author":"El-Darouti","year":"2015","journal-title":"Arch. Dermatol. Res."},{"key":"10.1016\/j.cyto.2015.09.017_b0385","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1136\/bmj.321.7258.424","article-title":"Th1 and Th2 responses: what are they?","volume":"321","author":"Berger","year":"2000","journal-title":"BMJ"},{"key":"10.1016\/j.cyto.2015.09.017_b0390","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1056\/NEJMoa1314768","article-title":"Dupilumab treatment in adults with moderate-to-severe atopic dermatitis","volume":"371","author":"Beck","year":"2014","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.cyto.2015.09.017_b0395","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1016\/j.jaci.2014.10.013","article-title":"Dupilumab improves the molecular signature in skin of patients with moderate-to-severe atopic dermatitis","volume":"134","author":"Hamilton","year":"2014","journal-title":"J. Allergy Clin. Immunol."},{"key":"10.1016\/j.cyto.2015.09.017_b0400","series-title":"Principles of Molecular Medicine","author":"Runge","year":"2007"},{"key":"10.1016\/j.cyto.2015.09.017_b0405","first-page":"123","article-title":"Dupilumab: a novel treatment for asthma","volume":"7","author":"Vatrella","year":"2013","journal-title":"J. Asthma Allergy"},{"key":"10.1016\/j.cyto.2015.09.017_b0410","doi-asserted-by":"crossref","first-page":"135","DOI":"10.3324\/haematol.2008.001628","article-title":"Anti-CD20 monoclonal antibodies: historical and future perspectives","volume":"95","author":"Lim","year":"2010","journal-title":"Haematologica"},{"key":"10.1016\/j.cyto.2015.09.017_b0415","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.autrev.2005.05.006","article-title":"Rituximab: a promising therapy in systemic lupus erythematosus","volume":"5","author":"Thatayatikom","year":"2006","journal-title":"Autoimmun. Rev."},{"key":"10.1016\/j.cyto.2015.09.017_b0420","doi-asserted-by":"crossref","DOI":"10.1016\/j.jpeds.2006.01.041","article-title":"Rituximab therapy for childhood-onset systemic lupus erythematosus","volume":"148","author":"Willems","year":"2006","journal-title":"J. Pediatr."},{"key":"10.1016\/j.cyto.2015.09.017_b0425","doi-asserted-by":"crossref","first-page":"2993","DOI":"10.1002\/art.23902","article-title":"Highly sensitive B cell analysis predicts response to rituximab therapy in rheumatoid arthritis","volume":"58","author":"Dass","year":"2008","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.cyto.2015.09.017_b0430","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1016\/j.jaad.2004.06.007","article-title":"Therapy of refractory pemphigus vulgaris with monoclonal anti-CD20 antibody (rituximab)","volume":"51","author":"Morrison","year":"2004","journal-title":"J. Am. Acad. Dermatol."},{"key":"10.1016\/j.cyto.2015.09.017_b0435","doi-asserted-by":"crossref","first-page":"289","DOI":"10.5694\/j.1326-5377.2008.tb02030.x","article-title":"Treatment of severe pemphigus foliaceus with rituximab","volume":"189","author":"Fernando","year":"2008","journal-title":"Med. J. Aust."},{"key":"10.1016\/j.cyto.2015.09.017_b0440","unstructured":"M. Alter, M. Wittmann, B. V\u00f6lker, A. Kapp, T. Werfel, R. Gutzmer, Successful treatment of pemphigus foliaceus with rituximab. Report of 3 cases, Der Hautarzt; Zeitschrift fur Dermatologie, Venerologie, und verwandte Gebiete. 60 (2009) 743\u2013748."},{"key":"10.1016\/j.cyto.2015.09.017_b0445","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1684\/ejd.2013.2177","article-title":"The imbalance of Th17 and regulatory T cells in pemphigus patients","volume":"23","author":"Xu","year":"2013","journal-title":"Eur. J. Dermatol."},{"key":"10.1016\/j.cyto.2015.09.017_b0450","doi-asserted-by":"crossref","unstructured":"K. Shimoda, J. van Deursent, M.Y. Sangster, S.R. Sarawar, R.T. Carson, R.A. Tripp, et al., Lack of IL-4-induced Th2 response and IgE class switching in mice with disrupted State6 gene, 1996.","DOI":"10.1038\/380630a0"},{"key":"10.1016\/j.cyto.2015.09.017_b0455","doi-asserted-by":"crossref","unstructured":"K. Takeda, T. Tanaka, W. Shi, M. Matsumoto, M. Minami, S.-I. Kashiwamura, et al., Essential role of Stat6 in IL-4 signalling, 1996.","DOI":"10.1038\/380627a0"},{"key":"10.1016\/j.cyto.2015.09.017_b0460","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/S1074-7613(00)80439-2","article-title":"Stat6 is required for mediating responses to IL-4 and for the development of Th2 cells","volume":"4","author":"Kaplan","year":"1996","journal-title":"Immunity"},{"key":"10.1016\/j.cyto.2015.09.017_b0465","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1016\/S1074-7613(00)80142-9","article-title":"Ectopic expression of activated Stat6 induces the expression of Th2-specific cytokines and transcription factors in developing Th1 cells","volume":"11","author":"Kurata","year":"1999","journal-title":"Immunity"},{"key":"10.1016\/j.cyto.2015.09.017_b0470","doi-asserted-by":"crossref","first-page":"1755","DOI":"10.1084\/jem.181.5.1755","article-title":"Interleukin 12 signaling in T helper type 1 (Th1) cells involves tyrosine phosphorylation of signal transducer and activator of transcription (Stat) 3 and Stat4","volume":"181","author":"Jacobson","year":"1995","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.cyto.2015.09.017_b0475","doi-asserted-by":"crossref","unstructured":"W.E. Thierfelder, J.M. van Deursen, K. Yamamoto, R.A. Tripp, S.R. Sarawar, R.T. Carson, et al., Requirement for Stat4 in interleukin-12-mediated responses of natural killer and T cells, 1996.","DOI":"10.1038\/382171a0"},{"key":"10.1016\/j.cyto.2015.09.017_b0480","first-page":"11","article-title":"Impaired IL-12 responses and enhanced development of Th2 cells in Stat4-deficient mice","volume":"382","author":"Grusby","year":"1996","journal-title":"Nature"},{"key":"10.1016\/j.cyto.2015.09.017_b0485","doi-asserted-by":"crossref","first-page":"2223","DOI":"10.1002\/eji.1830230926","article-title":"Interleukin-4 and interleukin-10 synergize to inhibit cell-mediated immunity in vivo","volume":"23","author":"Powrie","year":"1993","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.cyto.2015.09.017_b0490","doi-asserted-by":"crossref","first-page":"3666","DOI":"10.4049\/jimmunol.158.8.3666","article-title":"Crossregulation between T helper cell (Th) 1 and Th2: inhibition of Th2 proliferation by IFN-gamma involves interference with IL-1","volume":"158","author":"Oriss","year":"1997","journal-title":"J. Immunol."},{"key":"10.1016\/j.cyto.2015.09.017_b0495","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1159\/000056375","article-title":"Pemphigus\u2013paradigm of autoantibody-mediated autoimmunity","volume":"14","author":"Hertl","year":"2001","journal-title":"Skin Pharmacol. Physiol."},{"key":"10.1016\/j.cyto.2015.09.017_b0500","doi-asserted-by":"crossref","first-page":"1772","DOI":"10.1056\/NEJMoa062930","article-title":"Treatment of pemphigus vulgaris with rituximab and intravenous immune globulin","volume":"355","author":"Ahmed","year":"2006","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.cyto.2015.09.017_b0505","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1007\/s12016-009-8140-3","article-title":"Immunogenicity of anti-TNF-\u03b1 agents in autoimmune diseases","volume":"38","author":"Aikawa","year":"2010","journal-title":"Clin. Rev. Allergy Immunol."},{"key":"10.1016\/j.cyto.2015.09.017_b0510","doi-asserted-by":"crossref","first-page":"1707","DOI":"10.2174\/156802606778194217","article-title":"Anti-TNF-\u03b1 antibody therapies in autoimmune diseases","volume":"6","author":"Chatzantoni","year":"2006","journal-title":"Curr. Top. Med. Chem."},{"key":"10.1016\/j.cyto.2015.09.017_b0515","doi-asserted-by":"crossref","first-page":"1308","DOI":"10.1134\/S0006297914120049","article-title":"Modern anti-cytokine therapy of autoimmune diseases","volume":"79","author":"Astrakhantseva","year":"2014","journal-title":"Biochemistry (Moscow)"},{"key":"10.1016\/j.cyto.2015.09.017_b0520","first-page":"69","article-title":"Association of the expression of IL-4 and IL-13 genes, IL-4 and IgE serum levels with allergic asthma","volume":"6","author":"Afshari","year":"2007","journal-title":"Iran. J. Allergy, Asthma Immunol."},{"key":"10.1016\/j.cyto.2015.09.017_b0525","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1081\/JAS-100107544","article-title":"Serum levels of interleukins (IL)-4, IL-5, IL-13, and interferon-\u03b3 in acute asthma","volume":"38","author":"Lee","year":"2001","journal-title":"J. Asthma"},{"key":"10.1016\/j.cyto.2015.09.017_b0530","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1016\/S0091-6749(98)70141-1","article-title":"Analysis of cytokine signaling in patients with extrinsic asthma and hyperimmunoglobulin E","volume":"102","author":"Miller","year":"1998","journal-title":"J. Allergy Clin. Immunol."}],"container-title":["Cytokine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043466615300703?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043466615300703?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,8,14]],"date-time":"2023-08-14T22:53:34Z","timestamp":1692053614000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1043466615300703"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,1]]},"references-count":106,"alternative-id":["S1043466615300703"],"URL":"https:\/\/doi.org\/10.1016\/j.cyto.2015.09.017","relation":{},"ISSN":["1043-4666"],"issn-type":[{"value":"1043-4666","type":"print"}],"subject":[],"published":{"date-parts":[[2016,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Interleukin 4 inhibition as a potential therapeutic in pemphigus","name":"articletitle","label":"Article Title"},{"value":"Cytokine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cyto.2015.09.017","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}